SCHEMBL25590732

SCHEMBL25590732

CCC(C)C(=N)N1CCN(C)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 1/20 0.42
▸ KDM4E B2RXH2 4/20 0.40
▸ ALDH1A1 P00352 3/20 0.40
▸ KDM4C Q9H3R0 1/20 0.40
▸ MGLL Q99685 2/20 0.39
▸ PHGDH O43175 1/20 0.39
▸ TDP1 Q9NUW8 2/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ CYP2C19 P33261 1/20 0.34
▸ LMNA P02545 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ ALOX15 P16050 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ DUSP3 P51452 1/20 0.31
▸ PTPN5 P54829 1/20 0.31
▸ PTPN11 Q06124 1/20 0.31
▸ RAB9A P51151 1/20 0.31
▸ NPC1 O15118 1/20 0.30
▸ HRH4 Q9H3N8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4011185 0.83 F2 (0.41) ALDH1A1MGLLPHGDHTDP1
Hydrochloric Acid SCHEMBL15212474 0.81 F2 (0.39) MGLLTDP1
Hydrochloric Acid SCHEMBL21359993 0.81 F2 (0.39) MGLLTDP1
Water SCHEMBL28947683 0.81 F2 (0.39) MGLLTDP1
SCHEMBL10312994 0.81 F2 (0.44) ALDH1A1MGLLPHGDHTDP1
Hydrochloric Acid SCHEMBL3788280 0.81 F2 (0.39) MGLLTDP1
SCHEMBL1106399 0.78 CYP1A2 (0.42) HTR1AKDM4EALDH1A1KDM4CMGLL
SCHEMBL20752396 0.78 CYP3A4 (0.42) ALDH1A1MGLLPHGDHCYP2C19LMNA
SCHEMBL11924531 0.75 HSD17B10 (0.56) HTR1AKDM4EALDH1A1KDM4CTDP1
SCHEMBL16435177 0.75 HSD17B10 (0.56) HTR1AKDM4EALDH1A1KDM4CTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3444251-B1 BIARYL COMPOUNDS USEFUL FOR THE TREATMENT OF HUMAN DISEASES IN ONCOLOGY, NEUROLOGY AND IMMUNOLOGY BIOGEN MA INC (US) 2023-06-07 — — EP disclosed
Send feedback